Spectrum Pharmaceuticals, Inc.SPPINASDAQ
Loading
Gross Profit Over TimeContracting
Percentile Rank27
5Y CAGR-22.6%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

5Y CAGR
-22.6%/yr
Long-term compound
Percentile
P27
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$22.87M+174.8%
2022$8.32M-
2021$0.00-
2020$0.00-100.0%
2019$10.61M-87.2%
2018$82.58M+1.8%
2017$81.15M-26.6%
2016$110.60M-18.0%
2015$134.87M-15.6%
2014$159.79M-